4
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Safe use of glucocorticoids

How to monitor patients taking these potent agents

Pages 145-154 | Published online: 17 May 2016

References

  • Kenny FM, Preeyasombat C, Migeon CJ, et al. Cortisol production rate. II. Normal infants, children, and adults. Pediatrics 1966: 37(1 Pt 1): 34–42
  • Esteban NV, Loughlin T, Yergey AL, et al. Daily Cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab 1991: 72(1): 39–45
  • Meikle AW, Tyler FH. Potency and duration of action of glucocorticoids: effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function. Am J Med 1977: 63(2): 200–7
  • Gustavson LE, Benet LZ. Pharmacokinetics of natural and synthetic glucocorticoids. In: Anderson DC, Winter JS, eds. Adrenal cortex. Stoneham, MA Butterworth, 1985: 235–79
  • Koop HO, Holodniy M, List AF. Fulminant Kaposi's sarcoma complicating long-term corticosteroid therapy. Am J Med 1987: 83(4): 787–9
  • Nashel DJ. Is atherosclerosis a complication of long-term corticosteroid treatment? Am J Med 1986: 80(5): 925–9
  • Fraser CG, Preuss FS, Bigford WD. Adrenal atrophy and irreversible shock associated with cortisone therapy. JAMA 1952: 144(Aug 23): 1542–5
  • Slaney G, Brooke BN. Postoperative collapse due to adrenal insufficiency following cortisone therapy. Lancet 1957: 1(Jun 8): 1167–70
  • Harnagel EE, Kramer WG. Severe adrenocortical insufficiency following joint manipulation: report of patient receiving cortisone orally. JAMA 1955: 158(17): 1518–20
  • Cunningham SK, Moore A, McKenna TJ. Normal Cortisol response to corticotropin in patients with secondary adrenal failure. Arch Intern Med 1983: 143(12): 2276–9
  • Lindholm J, Kehlet H. Re-evaluation of the clinical value of the 30 min ACTH test in assessing the hypothalamic-pituitary-adrenocortical function. Clin Endocrinol (Oxf) 1987: 26(1): 53–9
  • Plumpton FS, Besser GM, Cole PV. Corticosteroid treatment and surgery. 2. The management of steroid cover. Anaesthesia 1969: 24(1): 12–8
  • Graber AL, Ney RL, Nicholson WE, et al. Natural history of pituitary-adrenal recovery following long-term suppression with corticosteroids. J Clin Endocrinol 1965: 25(Jan): 11–6
  • Luengo M, Picado C, Del Rio L, et al. Treatment of steroid-induced osteopenia with calcitonin in corticosteroid-dependent asthma: a one-year follow-up study. Am Rev Respir Dis 1990: 142(1): 104–7
  • Reid IR, King AR, Alexander CJ, et al. Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). Lancet 1988: 1(8578): 143–6
  • Prummel MF, Wiersinga WM, Lips P, et al. The course of biochemical parameters of bone turnover during treatment with corticosteroids. J Clin Endocrinol 1991: 72(2): 382–6
  • Horber FF, Haymond MW. Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J Clin Invest 1990: 86(1): 265–72
  • Klein I, Parveen G, Gavaler JS, et al. Colonic polyps in patients with acromegaly. Ann Intern Med 1982: 97(1): 27–30

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.